CIFL (10)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE circular updating strike price intervals for 70 scrips in equity derivative contracts, effective from specified dates. | |||||||||||||||
BSE circular updating strike price intervals for 70 scrips in equity derivative contracts, effective from specified dates.
| |||||||||||||||
BSE circular specifying the strike price intervals for equity derivatives across 70+ securities for options trading. | |||||||||||||||
BSE circular specifying the strike price intervals for equity derivatives across 70+ securities for options trading.
| |||||||||||||||
BSE announces updated strike price intervals for equity derivatives across 70 scrips, ranging from ₹1 to ₹250 intervals based on underlying … | |||||||||||||||
BSE announces updated strike price intervals for equity derivatives across 70 scrips, ranging from ₹1 to ₹250 intervals based on underlying security price levels.
| |||||||||||||||
BSE updates strike price intervals for equity derivative contracts across various scrips, ranging from ₹1 to ₹250 depending on the … | |||||||||||||||
BSE updates strike price intervals for equity derivative contracts across various scrips, ranging from ₹1 to ₹250 depending on the underlying security.
| |||||||||||||||
BSE surveillance requested clarifications from Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance … | |||||||||||||||
BSE surveillance requested clarifications from Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance regarding significant increase in trading volumes. All companies confirmed compliance with disclosure requirements and stated no price-sensitive information was withheld.
| |||||||||||||||
Three companies (Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance) clarified to BSE that they … | |||||||||||||||
Three companies (Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance) clarified to BSE that they have disclosed all material information and have no undisclosed price-sensitive information regarding recent volume spikes in their securities.
| |||||||||||||||
List of securities subject to Reversal Trade Cancellation Mechanism (RTCM) for December 2025, covering over 300 stocks where specific trade … | |||||||||||||||
List of securities subject to Reversal Trade Cancellation Mechanism (RTCM) for December 2025, covering over 300 stocks where specific trade cancellation procedures will apply. | |||||||||||||||
BSE announces listing of additional securities from 13 companies under Employee Stock Option schemes, effective August 7, 2025. | |||||||||||||||
BSE announces listing of additional securities from 13 companies under Employee Stock Option schemes, effective August 7, 2025.
| |||||||||||||||
New debt securities worth Rs. 50 crore issued by Capital India Finance Limited listed on BSE Debt segment with 9.55% interest rate. | |||||||||||||||
New debt securities worth Rs. 50 crore issued by Capital India Finance Limited listed on BSE Debt segment with 9.55% interest rate.
| |||||||||||||||
New debt securities of Capital India Finance Limited listed on BSE Debt segment with 9.55% interest rate and 3-year tenure. | |||||||||||||||
New debt securities of Capital India Finance Limited listed on BSE Debt segment with 9.55% interest rate and 3-year tenure.
| |||||||||||||||